Geneticist Gary Peltz leveraged Claude's Co-Scientist AI to identify repurposed drugs that could treat liver fibrosis.
- •Co-Scientist proposed three drug candidates, two of which blocked fibrosis and promoted liver cell regeneration in human liver cell tests.
- •Peltz's manual drug selections showed no benefit, while both AI-identified drugs proved effective.
- •Vorinostat, a cancer drug identified by Co-Scientist, blocked 91% of damage responses driving liver scarring.
- •Co-Scientist's approach targeted drugs that reshape gene activity rather than single fibrosis pathways.
- •One successful drug had been mentioned in only a handful of papers, showing AI's ability to find overlooked scientific insights.
This summary was automatically generated by AI based on the original article and may not be fully accurate.
Deepmind
Google Cloud